Dr. Dennis’ research focuses on pediatric acute lymphoblastic leukemia. She is interested in identifying novel therapeutic options for children who have relapsed or remain refractory to the currently available leukemia therapies. Dr. Dennis is involved in clinical trials through the Children’s Oncology Group, Nationwide Children’s Hospital and The Ohio State University’s Experimental Therapeutics program.